Thrombus-related diseases have a high mortality rate and are seriously threatening human
life and health. Nattokinase (NK), which has a strong thrombolytic effect, can treat thrombotic …

Nattokinase (NK), a potent thrombolytic enzyme that dissolves blood clots, is highly used in
the treatment of cardiovascular disorders. However, its effective delivery remains demanding …

Thrombotic disease has become one of the leading causes of mortality among humans
globally. Nattokinase (NK), a novel thrombolytic agent, has attracted the attention of …

With the frequent occurrence of thrombus diseases, thrombus has become a factor
endangering human health. Nattokinase (NK) is a new generation of thrombolytic drug with …

Thrombosis has become one of the major diseases harmful to human health. The new‐
generation thrombolytic drug nattokinase (NK) has been used in the treatment of thrombosis …

Nattokinase (NK) has been used as a new generation thrombolytic drug, due to its high
safety, low cost and low side effects. However, it is sensitive to external environment and …

Abstract Eudragit L100-55-halloysite nanotubes (EL100-55, HNTs) nanocomposite
microcapsules were introduced to release nattokinase (NK) and avoid the limitations of oral …

The present research work describes the downstreaming of nattokinase (NK) produced by
Bacillus subtilis under solid state fermentation; and the role of efficient oral formulation of …

Thrombotic events affect many individuals in a number of ways, all of which can cause
significant morbidity and mortality. Nattokinase (NK), as a novel thrombolytic drug, has been …

Cancer-associated thrombus (CAT) impedes delivery of nanoparticles to tumor sites and
also inhibits the ability of immune cells to detect and attack these tumors, particularly in …